NCT05532956View on ClinicalTrials.gov

Evaluation of the Impact of Tricuspid Regurgitation on Patients Lives. Exploration of Experience and Impact on a Daily Basis.

UnknownOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2022

Primary Completion Date

September 30, 2022

Study Completion Date

October 31, 2022

Conditions
Severe Tricuspid Regurgitation Medically Treated and Not Operated (Without Valve Replacement or Repair)
Sponsors

Collaborators (1)

Edwards Lifesciences
All Listed Sponsors
collaborator

Edwards Lifesciences

INDUSTRY

lead

Gérond'if

OTHER